Predicting therapeutic response to oral ketamine for chronic suicidal ideation: a Bayesian network for clinical decision support - Beaudequin D, Can AT, Dutton M, Jones M, Gallay C, Schwenn P, Yang C, Forsyth G, Simcock G, Hermens DF, Lagopoulos J.

BACKGROUND: The glutamatergic modulator ketamine has been shown to result in rapid reductions in both suicidal ideation (SI) and depressive symptoms in clinical trials. There is a practical need for identification of pre-treatment predictors of ketamine re...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news